# Biomerica, Inc. (BMRA)

> Source: Nexqual · https://nexqual.com/BMRA · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, Biomerica, Inc. (BMRA), nexqual.com/BMRA" · informational, not investment advice.

**Price:** USD 1.88 (+4.17% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 1.8 · day 1.81–1.92 · 52w 1.45–3.21 · market cap $8.6M · NCM

## Key facts
- Total return with dividends: 1Y -37.5% vs S&P 500 +18.1%; 5Y -95.8% vs S&P 500 +85.1%.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2021-10-11) |
|---|---|---|
| Total return | -37.5% | -95.8% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -37.6% | -46.8% |
| Volatility (annualized) | 57.6% | 82.4% |
| Max drawdown | -53.4% (Oct 2025→Jul 2026) | -96.6% (Oct 2021→Jul 2026) |

## Peers
AYTU (Aytu BioPharma, Inc.) USD 2.01 +1.01% · BNBX (BNB Plus Corp.) USD 0.12 -7.69% · CFOR (CapForce Inc.) USD 4.04 +1.94% · SNOA (Sonoma Pharmaceuticals, Inc.) USD 1.15 -2.54% · CODX (Co-Diagnostics, Inc.) USD 0.72 -32.85%

## More
Full page: https://nexqual.com/BMRA · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt